- Home
- NTRB vs GROW Comparison
NTRB vs GROW Comparison
Compare NTRB & GROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NTRB | GROW |
|---|---|---|
| Founded | 2016 | 1968 |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Industrial Specialties | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 35.3M | 32.7M |
| IPO Year | N/A | 1995 |
Fundamental Metrics
Financial Performance| Metric | NTRB | GROW |
|---|---|---|
| Price | $3.06 | $3.14 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 9.7K | ★ 36.5K |
| Earning Date | 05-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 3.53% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $23,850,609.00 |
| Revenue This Year | $30.17 | N/A |
| Revenue Next Year | $3,394.36 | N/A |
| P/E Ratio | ★ N/A | $11.67 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.90 | $2.23 |
| 52 Week High | $11.68 | $3.65 |
Technical Indicators
Market Signals| Indicator | NTRB | GROW |
|---|---|---|
| Relative Strength Index (RSI) | 36.53 | 66.03 |
| Support Level | $2.90 | $3.10 |
| Resistance Level | $3.67 | $3.37 |
| Average True Range (ATR) | 0.19 | 0.12 |
| MACD | -0.03 | 0.03 |
| Stochastic Oscillator | 14.58 | 68.33 |
Price Performance
Historical ComparisonAbout NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About GROW U.S. Global Investors Inc.
US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.